• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Varian

Varian

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Research and Markets: Global Oncology Information System Market 2015 by Software, Application, End User - Forecasts to 2019

    Research and Markets: Global Oncology Information System Market 2015 by Software, Application, End User - Forecasts to 2019

  2. Varian Medical Systems to Exhibit Digital Radiography Components at the CMEF in China

    Varian Medical Systems to Exhibit Digital Radiography Components at the CMEF in China

  3. Research and Markets: Global Fluoroscopy and Mobile C-arms Market 2015-2019 with Aton, GE Healthcare, Philips Healthcare, Shimadzu & Siemens Healthcare Dominating

    Research and Markets: Global Fluoroscopy and Mobile C-arms Market 2015-2019 with Aton, GE Healthcare, Philips Healthcare, Shimadzu & Siemens Healthcare Dominating

  4. Research and Markets: Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021

    Research and Markets: Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021

  5. Cancer Experts Detail How 'Big Data' Plays a Critical Role in Improving Clinical Decision-Making in Oncology Treatments at 3rd ESTRO Forum

    Cancer Experts Detail How 'Big Data' Plays a Critical Role in Improving Clinical Decision-Making in Oncology Treatments at 3rd ESTRO Forum

  6. Health Care: 3 Picks in a More Expensive Sector

    Despite the sector looking slightly overvalued overall, we still see stocks that offer attractive valuations across the different industries.

  7. Greece’s Darkest Hour Before Its Dawn

    Varian Medical Systems' VAR third-quarter results were in line with our expectations, and we are leaving our fair value estimate unchanged. Overall, revenue increased 7%, and net orders rose 13%, bringing the company's backlog at quarter-end to $1.6 billion. Revenue for the oncology system segment ...

  8. Health Care: A Strong Run, but Some Stocks Still Look Undervalued

    While the sector looks slightly overvalued overall, we still see several stocks that offer attractive valuations across the different industries.

  9. Research Roundup: Foreign Diversification, Social Comparisons and Consumer Identity

    Varian Medical's VAR third-quarter fiscal 2006 results fall right in line with the seasonal patterns we expected from our current near-term modeling assumptions. The oncology group notched 14% growth, and customer demand continues to reflect a shift toward Varian's next-generation IGRT technology, ...

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.